Comparison of two calcium blockers on hemodynamics, left ventricular mass, and coronary vasodilatory in advanced hypertension

American Journal of Hypertension

Volumn 14, Issue 3, 2001, Pages 231-240

  Diamond, Joseph A ^a   Krakoff, Lawrence R ^a   Goldman, Adam ^a   Coplan, Neil ^b   Gharavi, Ali ^a   Martin, Kevin ^a   Goldsmith, Rochelle ^a   Henzlova, Milena J ^a   Machac, Joseph ^a   Phillips, Robert A ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b LENOX HILL HOSPITAL   (United States)

Author keywords

Calcium channel antagonists; Coronary microcirculation; Hypertension; Hypertrophy

Indexed keywords

ADENOSINE; ADRENALIN; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE; NORADRENALIN; RENIN; THALLIUM 201; VERAPAMIL;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; NORADRENALIN BLOOD LEVEL; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CORONARY CIRCULATION; CORONARY VESSELS; DIASTOLE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART RATE; HEART VENTRICLES; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; SYSTOLE; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT; VERAPAMIL;

EID: 0035092353     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(00)01267-X     Document Type: Article

References (43)

1. Calcium entry blockers in the treatment of hypertension
2. Normalization of left ventricular mass and associated changes in neurohormones and atrial natriuretic peptide after one year of sustained nifedipine therapy for severe hypertension
3. Once-daily verapamil in the treatment of mild-to-moderate hypertension: A double-blind placebo-controlled dose-ranging study
4. Comparison of ambulatory blood pressure and amounts of left ventricular hypertrophy in men versus women with similar levels of hypertensive clinic blood pressures
5. Interobserver variability of left ventricular measurements in a population of predominantly obese hypertensives using simultaneously acquired and displayed M-mode and 2D cine echocardiography
6. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight
7. Hypertensive heart disease
8. Noninvasive assessment of load reduction in patients with asymptomatic aortic regurgitation
9. Determinants of abnormal left ventricular filling in early hypertension
10. Linear relationship between the distribution of thallium-201 and blood flow in ischemic and non-ischemic myocardium during exercise
11. Effects of adenosine on human coronary arterial circulation
12. Quantitative adenosine-thallium perfusion imaging for assessing coronary flow reserve in arterial hypertension
13. Effect of long-term eprosartan versus enalapril antihypertensive therapy on left ventricular mass and coronary flow reserve in stage I-II hypertension
14. Determinants of atrial natriuretic factor in the adult respiratory distress syndrome
15. New Doppler echocardiographic applications for the study of diastolic function
16. Echocardiographic and other noninvasive measurements of cardiac hemodynamics and ventricular function
17. Dose-related increase in mortality in patients with coronary heart disease
18. Pulse rate, coronary heart disease, and death: The NHANES I epidemiologic follow-up study
19. Influence of heart rate on mortality among persons with hypertension: The Framingham study
20. Heart rate and the cardiovascular risk
21. The relationship between resting heart rate and all-cause, cardiovascular and cancer mortality
22. Heart-rate-lowering calcium antagonists (HRL-CA) in hypertensive post-MI patients
23. Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II - DAVIT II)
24. Mechanisms whereby calcium channel antagonists may protect patients with coronary artery disease
25. Pharmacological differences between calcium antagonists
26. Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion
27. Prognostic significance of exercise blood pressure and heart rate in middle-aged men
28. Physical fitness as a predictor of mortality among healthy, middle-aged Norwegian men
29. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies
30. Regression of hypertensive left ventricular hypertrophy and left ventricular diastolic dysfunction
31. Doppler echocardiographic analysis of left ventricular filling in treated hypertensive patients
32. Effect of nitrendipine on coronary flow and ventricular hypertrophy in hypertension
33. Coronary interactions betwen nifedipine and adenosine in the intact dog heart
34. The effect of diltiazem on coronary flow reserve in humans
35. Changes in human coronary flow reserve after administration of intracoronary diltiazem
36. Effect of diltiazem on coronary flow reserve in patients with microvascular angina
37. Response of hypertensive left ventricular hypertrophy and coronary microvascular disease to calcium antagonists
38. Clinical pharmacokinetics of nifedipine gastrointestinal therapeutic system: A controlled-release formulation of nifedipine
39. Innovative drug delivery systems in cardiovascular medicine: Nifedipine GITS and clonidine TTS
40. Comparative efficacy, safety and pharmacokinetics of verapamil SR vs verapamil IR in hypertensive patients
41. Effects of calcium entry blockade on hypertension-induced left ventricular hypertrophy
42. Effect of nifedipine GITS on left ventricular mass and diastolic function in severe hypertension